Vanda Pharmaceuticals Inc.·4

Feb 19, 11:22 AM ET

Irish Stephanie Rast 4

4 · Vanda Pharmaceuticals Inc. · Filed Feb 19, 2010

Insider Transaction Report

Form 4
Period: 2010-02-18
Irish Stephanie Rast
Sr. VP, Acting CFO/Treasurer
Transactions
  • Exercise/Conversion

    Common Stock

    2010-02-18+20,00022,449 total
  • Exercise/Conversion

    Restricted Stock Units

    2010-02-1820,0000 total
    Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units represented a contingent right to receive a share of the Issuer's common stock which vested on December 31, 2009.
  • [F2]N/A

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION